MarketCap
Arbutus Biopharma Corporation ABUS
€ 3.95
1.92%
Facebook
X
Telegram
Land |
 Kanada |
IPO-Jahr |
- |
Branche |
Pharmaeinzelhändler |
Börse |
NASDAQ GLOBAL |
Anteile |
192 M |
Marktkapitalisierung |
$ 853 M |
EBITDA (LTM) |
$ -37.8 M |
P/E (LTM) |
-30.294118 |
P/S (LTM) |
70.065891 |
EPS (LTM) |
-0.17 |
Andere Aktien der Branche "Pharmaeinzelhändler"
| Name | Preis | % 24h | Marktkapitalisierung | Börse | Land | |
|---|---|---|---|---|---|---|
 |
Nektar Therapeutics
NKTR
|
$ 43.58 | 2.2 % | $ 735 M | Nasdaq Global Select Market,SPB |  USA |
 |
Nkarta
NKTX
|
$ 2.58 | 0.59 % | $ 191 M | Nasdaq Global Select Market | USA |
 |
NanoViricides
NNVC
|
$ 1.28 | 1.59 % | $ 25.8 M | NYSE American | USA |
 |
Nurix Therapeutics
NRIX
|
$ 22.99 | 0.51 % | $ 1.99 B | Nasdaq Global Select Market,SPB | USA |
 |
Intellia Therapeutics
NTLA
|
$ 12.26 | 1.16 % | $ 1.33 B | Nasdaq Global Market,SPB | USA |
 |
Nuvation Bio
NUVB
|
$ 5.14 | 1.07 % | $ 1.76 B | NYSE | USA |
 |
Novavax
NVAX
|
$ 10.46 | 0.24 % | $ 1.69 B | Nasdaq Global Select Market | USA |
 |
Novo Nordisk A/S
NVO
|
$ 37.32 | 0.48 % | $ 166 B | NYSE |  Danmark |
 |
Novartis AG
NVS
|
$ 141.0 | 0.01 % | $ 273 B | NYSE |  Schweiz |
 |
NextCure
NXTC
|
$ 5.09 | 2.62 % | $ 14.5 M | Nasdaq Global Select Market | USA |
 |
Ocugen
OCGN
|
$ 1.02 | 2.0 % | $ 319 M | Nasdaq Capital Market | USA |
 |
Ocular Therapeutix
OCUL
|
$ 6.96 | 0.82 % | $ 1.3 B | Nasdaq Global Select Market | USA |
 |
Oragenics
OGEN
|
$ 0.49 | 1.57 % | $ 1.06 M | NYSE American | USA |
 |
Olema Pharmaceuticals
OLMA
|
$ 8.23 | 1.21 % | $ 716 M | Nasdaq Global Select Market | USA |
 |
Omeros Corporation
OMER
|
$ 18.61 | 0.76 % | $ 1.18 B | Nasdaq Global Select Market | USA |
 |
Oncolytics Biotech
ONCY
|
$ 0.63 | 1.21 % | $ 60.4 M | Nasdaq Global Select Market | Canada |
 |
ORIC Pharmaceuticals
ORIC
|
$ 12.21 | 0.16 % | $ 1.07 B | Nasdaq Global Select Market | USA |
 |
Oramed Pharmaceuticals
ORMP
|
$ 4.49 | 0.22 % | $ 186 M | Nasdaq Global Select Market |  Israel |
 |
Outlook Therapeutics
OTLK
|
$ 0.59 | 3.13 % | $ 20.5 M | Nasdaq Global Select Market | USA |
 |
Ovid Therapeutics
OVID
|
$ 2.38 | 0.21 % | $ 310 M | Nasdaq Global Select Market | USA |
 |
Passage Bio
PASG
|
$ 4.12 | 2.36 % | $ 13.2 M | Nasdaq Global Select Market | USA |
 |
Puma Biotechnology
PBYI
|
$ 9.51 | 0.15 % | $ 476 M | Nasdaq Global Select Market | USA |
 |
Processa Pharmaceuticals
PCSA
|
$ 1.62 | 0.62 % | $ 2.12 M | Nasdaq Global Select Market | USA |
 |
Vaxcyte
PCVX
|
$ 56.48 | 0.77 % | $ 7.69 B | Nasdaq Global Select Market | USA |
 |
Pfizer
PFE
|
$ 27.8 | 0.02 % | $ 158 B | NYSE,SPB | USA |
 |
Precigen
PGEN
|
$ 8.54 | 4.02 % | $ 2.67 B | Nasdaq Global Select Market | USA |
 |
Pharming Group N.V.
PHAR
|
$ 9.75 | 0.15 % | $ 6.72 B | Nasdaq Global Select Market |  Niderland |
|
Phathom Pharmaceuticals
PHAT
|
$ 6.92 | 1.77 % | $ 505 M | Nasdaq Global Select Market,SPB | USA |
 |
Phio Pharmaceuticals Corp.
PHIO
|
$ 0.99 | 0.5 % | $ 5.92 M | Nasdaq Capital Market | USA |
 |
Pliant Therapeutics
PLRX
|
$ 1.03 | 0.48 % | $ 63.2 M | Nasdaq Global Select Market | USA |
 |
Protalix BioTherapeutics
PLX
|
$ 2.71 | 1.12 % | $ 213 M | NYSE American | Israel |
 |
PMV Pharmaceuticals
PMVP
|
$ 1.79 | 2.29 % | $ 94 M | Nasdaq Global Select Market | USA |
 |
Praxis Precision Medicines
PRAX
|
$ 295.51 | 3.0 % | $ 6.65 B | Nasdaq Global Select Market,SPB | USA |
 |
PainReform Ltd.
PRFX
|
$ 0.92 | 0.04 % | $ 596 K | Nasdaq Capital Market | Israel |
 |
Prelude Therapeutics Incorporated
PRLD
|
$ 3.67 | 0.51 % | $ 282 M | Nasdaq Global Select Market | USA |
 |
ProQR Therapeutics N.V.
PRQR
|
$ 1.64 | 0.31 % | $ 173 M | Nasdaq Global Market | Niderland |
 |
Prothena Corporation plc
PRTA
|
$ 8.36 | 0.35 % | $ 450 M | Nasdaq Global Select Market,SPB | USA |
 |
PTC Therapeutics
PTCT
|
$ 63.46 | 1.06 % | $ 5.05 B | Nasdaq Global Select Market,SPB | USA |
 |
Protagonist Therapeutics
PTGX
|
$ 140.06 | 0.63 % | $ 8.9 B | Nasdaq Global Select Market | USA |
 |
Pulmatrix
PULM
|
$ 1.57 | 1.95 % | $ 5.73 B | Nasdaq Global Select Market | USA |
 |
PolyPid Ltd.
PYPD
|
$ 5.19 | 1.49 % | $ 84.9 M | Nasdaq Global Select Market | Israel |
 |
uniQure N.V.
QURE
|
$ 23.46 | 0.39 % | $ 1.35 B | Nasdaq Global Select Market | Niderland |
 |
Ultragenyx Pharmaceutical
RARE
|
$ 15.22 | 3.19 % | $ 1.5 B | Nasdaq Global Select Market,SPB | USA |
 |
Rocket Pharmaceuticals
RCKT
|
$ 2.56 | 1.16 % | $ 284 M | Nasdaq Global Select Market | USA |
 |
Arcus Biosciences
RCUS
|
$ 24.44 | 1.41 % | $ 2.62 B | NYSE,SPB | USA |
 |
RedHill Biopharma Ltd.
RDHL
|
$ 0.5 | 4.17 % | $ 6.16 B | Nasdaq Global Market | Israel |
 |
Dr. Reddy's Laboratories Limited
RDY
|
$ 12.25 | 0.37 % | $ 10.2 B | NYSE |  India |
 |
Regeneron Pharmaceuticals
REGN
|
$ 735.2 | 0.05 % | $ 76.9 B | Nasdaq Global Select Market,SPB | USA |
 |
Replimune Group
REPL
|
$ 13.07 | 0.3 % | $ 1.21 B | Nasdaq Global Select Market | USA |
 |
Rafael Holdings
RFL
|
$ 1.54 | 2.67 % | $ 45.3 M | NYSE | USA |